Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors

Neurochemical Research

Volumn 24, Issue 5, 1999, Pages 659-667

  Squires, Richard F ^a   Saederup, Else ^a  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

5 HT3 receptor blockers; Anti psychotic drugs; GABA(A) antagonists

Indexed keywords

AZASETRON; BEMESETRON; CLOZAPINE; NEUROLEPTIC AGENT; TROPISETRON; ZACOPRIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; INTERNEURON; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR BLOCKING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZAMIDES; BICYCLO COMPOUNDS, HETEROCYCLIC; CLOZAPINE; DRUG INTERACTIONS; FEMALE; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; ONDANSETRON; QUINACRINE; QUIPAZINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; SULFUR RADIOISOTOPES; TROPANES;

ANIMALIA;

EID: 0032937568     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021052409140     Document Type: Article

References (20)

1. 3 receptor, a serotonin-gated ion channel. Science 254: 432-437.
2. 35S]TBPS binding. Brain Res. 414:357-364.
3. 3 Receptors. Med. Res. Rev. 10:441-475.
4. Hunt, P., and Clements-Jewery, S. 1981. A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interaction. Neuropharmacol. 20:357-361.
5. Curtis, D. R., and Malick, R. 1985. Glycine antagonism by RU 5135. Eur. J. Pharmacol. 110:383-384.
6. Gerlach, J. 1991. New antipsychotics: Classification, effiacy, and adverse effects. Schizophrenia Bull. 17:289-309.
7. White, A., Corn, T. H., Feetham C., and Faulconbridge, C. 1991. Ondansetron in the treatment of schizophrenia. Lancet 337:1173.
8. 3 antagonists in neuropsychiatrie disorders. CNS Drugs 3:363-392.
9. A current of rat central nervous system neurons. Eur. J. Pharmacol. 337:87-94.
10. 3 receptors in the cerebral cortex and superior cervical ganglion of the rat. Eur. J. Pharmacol. 182:465-472.
11. Squires, R. F., and Saederup, E. 1991. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: More support for a continuum hypothesis of "functional" psychosis. Neurochem. Res. 16:1099-1111.
12. A receptors. Neurochem. Res. 22:151-162.
13. Korpi, E. R., Wong, G., and Lüddens, H. 1995. Subtype specificity of γ-aminobutyric acid type A receptor antagonism by clozapine. N-S. Arch. Pharmacol. 352:365-373.
14. A receptors. Neurochem. Res. 23: 1283-1290.
15. 35S]t-Butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to γ-aminobutyric acid-A and ion recognition sites. Mol. Pharmacol. 23:326-336.
16. Seifert, J., and Casida, J. E. 1985. Solubilization and detergent effects on interactions of some drugs and insecticides with the t-butylbicyclophosphorothionate binding site within the γ-aminobutyric acid receptor-ionophore complex. J. Neurochem. 44:110-116.
17. 35S]t-butylbicyclophosphorothionate binding sites reveals complicated molecular arrangements of the GABA/ benzodiazepine receptor chloride channel complex. Biochem. Pharmacol. 34:3633-3642.
18. A receptor subunit mRNAs in the rat brain. I. telencephalon, diencephalon, mesencephalon. J. Neurosci. 12:1040-1062.
19. Benke, D., Fritschy, J-M., Trzeciak, A., Bannwarth, W., and Mohler, H. 1994. Distribution, prevalence, and drug binding profile of γ-aminobutyric acid type A receptor subtypes differing in the β-subunit variant. J. Biol. Chem. 269:27100-27107.
20. A-receptor heterogeneity in the adult rat brain differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359:154-194.